EAM
CRBP icon

EverPoint Asset Management’s Corbus Pharmaceuticals CRBP Stock Holding History

EverPoint Asset Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$867K Buy
+3,420
New +$784K 0.02% 379

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

EverPoint Asset Management's CRBP Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Corbus Pharmaceuticals (CRBP) in Q4 2016: 3,420 shares worth $867K. The stake represents 0.02% of the portfolio and ranks #379 among its holdings.

49 funds tracked by Wall St. Rank hold CRBP as of Q4 2016.

  • EverPoint Asset Management held 3,420 shares of Corbus Pharmaceuticals worth $867K as of Q4 2016.
  • Corbus Pharmaceuticals was a new EverPoint Asset Management position in Q4 2016.
  • Corbus Pharmaceuticals made up 0.02% of EverPoint Asset Management's portfolio in Q4 2016, its #379 holding.
  • 49 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.